To evaluate the effects of AβC7-1 and AβC7-14 in vivo, we tested their impact on Aβ42 aggregation and Aβ42-induced pathogenicity in an established C. elegans model of Alzheimer’s disease. This evidence concerns the gene ABCB7 and early-onset autosomal dominant Alzheimer disease.